Insider Trading Report: Top 10 Insider buys of the month (page 1 of 12)

This insider trading report lists Top 10 Insider buys of the month, updated on October 19, 2018. (Actually we included top 50 insiders that scored the most in insider trading value).


Top 10 Insider buys of the month, Updated October 19, 2018 (page 1 of 12) (Actually top 50 issuers are included)
Symbol Issuer Insider Name   Shares     Price     Value($)   Trade
Date
CNRLX City National Rochdale Select Strategies Fund Wolford James R. 2,250,804 9.33 21,000,001 2017-09-18
  Wolford James R. 10,613,944 9.61 102,000,001 2017-12-21
  Wolford James R. 29,732,408 10.09 299,999,996 2017-08-28
UROV Urovant Sciences Ltd. Machado Patrick (10% Owner) 2,678,571 14.00 37,499,994 2018-10-01
  Roivant Sciences Ltd. (10% Owner) 2,678,571 14.00 37,499,994 2018-10-01
  Viking Long Fund Master Ltd. 2,678,571 14.00 37,499,994 2018-10-01
  Qvt Fund V Lp (10% Owner) 2,678,571 14.00 37,499,994 2018-10-01
  Svf Holdings (uk) Llp (10% Owner) 2,678,571 14.00 37,499,994 2018-10-01
  Shabet Rose Sharon 2,678,571 14.00 37,499,994 2018-10-01
  Oren Dan 2,678,571 14.00 37,499,994 2018-10-01
  Lo Andrew (10% Owner) 2,678,571 14.00 37,499,994 2018-10-01
REIS Reis, Inc. Moodys Corp /de/ (10% Owner) 11,570,797 23.00 266,128,331 2018-10-13
STON Stonemor Partners Lp Axelrod Andrew 640 4.50 2,880 2018-08-15
  Axelrod Andrew 400 4.50 1,800 2018-08-13
  Axelrod Andrew 3,120 4.48 13,965 2018-09-19
  Axelrod Andrew 19,040 4.49 85,394 2018-09-18
  Axelrod Andrew 6,420 4.34 27,837 2018-09-17
  Axelrod Andrew 20,000 4.43 88,699 2018-09-14
  Axelrod Andrew 16,071 4.49 72,142 2018-09-13
  Axelrod Andrew 10,400 4.45 46,228 2018-09-12
  Axelrod Andrew 9,795 4.49 43,930 2018-09-11
  Axelrod Andrew 19,200 4.54 87,168 2018-09-10
  Axelrod Andrew 3,308 4.49 14,859 2018-08-29
  Axelrod Andrew 4,240 4.50 19,058 2018-08-28
  Axelrod Andrew 10,717 4.49 48,119 2018-08-27
  Axelrod Andrew 2,176 4.48 9,748 2018-08-20
  Axelrod Andrew 12,800 4.46 57,152 2018-08-09
  Axelrod Andrew 400 4.50 1,800 2018-08-08
  Axelrod Andrew 1,520 4.50 6,840 2018-08-07
  Axelrod Andrew 7,200 4.49 32,306 2018-08-06
  Axelrod Andrew 6,848 4.36 29,823 2018-08-03
  Axelrod Andrew 1,571 4.49 7,053 2018-08-31
  Axelrod Andrew 10,478 4.42 46,302 2018-09-07
  Axelrod Andrew 2,044 4.50 9,191 2018-08-30
  Axelrod Andrew 20,000 4.45 89,060 2018-09-06
  Axelrod Andrew 13,772 4.47 61,615 2018-09-05
  Axelrod Andrew 20,000 4.46 89,200 2018-09-04
  Axelrod Andrew 6,560 4.99 32,760 2018-09-28
  Axelrod Andrew 16,000 5.14 82,224 2018-10-02
  Axelrod Andrew 6,400 5.15 32,985 2018-10-05
  Axelrod Andrew 10,632 5.19 55,222 2018-10-04
  Axelrod Andrew 2,091 5.17 10,802 2018-10-03
  Axelrod Andrew 27,120 5.19 140,752 2018-10-10
  Axelrod Andrew 19,051 5.15 98,169 2018-10-09
  Axelrod Andrew 8,483 5.19 44,052 2018-10-08
  Axelrod Andrew 51,225 5.33 272,875 2018-10-12
  Axelrod Andrew 10,216 5.19 53,061 2018-10-11
  Axelrod Andrew 1,600 5.38 8,606 2018-10-15
  Axelrod Andrew 35,000 5,068.00 177,380,000 2018-10-18
  Axelrod Andrew 20,000 4.97 99,340 2018-10-17
  Axelrod Andrew 7,616 5.29 40,250 2018-10-16
ETTX Entasis Therapeutics Holdings Inc. Novo Holdings A/s (10% Owner) 1,089,835 15.00 16,347,525 2018-09-28
  Coulter James G 262,539 15.00 3,938,085 2018-09-28
  Wheeler Kurt (10% Owner) 453,395 15.00 6,800,925 2018-09-28
  Astrazeneca Ab (10% Owner) 246,666 15.00 3,699,990 2018-09-28
  Topper James N (Director) 375,887 15.00 5,638,305 2018-09-28
  Powell Michael (10% Owner) 337,724 15.00 5,065,860 2018-09-28
  Preston Heather (Director) 337,724 15.00 5,065,860 2018-09-28
  Pivotal Bioventure Partners Fund I U.g.p., Ltd (10% Owner) 337,724 15.00 5,065,860 2018-09-28
  Galakatos Nicholas (Director) 453,395 15.00 6,800,925 2018-09-28
  Fhm Life Sciences Viii, L.p. (10% Owner) 375,887 15.00 5,638,305 2018-09-28
FATE Fate Therapeutics Inc Green Jeremy 3,703,704 13.50 50,000,004 2018-09-25
KALA Kala Pharmaceuticals, Inc. Shah Rajeev M. 2,424,242 8.25 19,999,996 2018-10-03
  Kolchinsky Peter 2,424,242 8.25 19,999,996 2018-10-03
  Grunberg Gregory 606,060 8.25 4,999,995 2018-10-05
GCP Gcp Applied Technologies Inc. G Holdings Inc. 84,298 26.39 2,224,539 2018-09-21
  G Holdings Inc. 214,600 26.15 5,612,219 2018-10-01
  G Holdings Inc. 25,350 26.48 671,318 2018-09-28
  G Holdings Inc. 53,575 26.09 1,397,986 2018-09-27
  G Holdings Inc. 35,000 26.20 917,140 2018-10-04
  G Holdings Inc. 49,080 26.22 1,286,926 2018-10-03
  G Holdings Inc. 17,820 26.40 470,430 2018-10-02
  G Holdings Inc. 345,053 25.68 8,862,341 2018-10-09
  G Holdings Inc. 15,321 26.23 401,839 2018-10-08
  G Holdings Inc. 117,000 26.16 3,060,252 2018-10-05
  G Holdings Inc. 164,700 24.87 4,096,583 2018-10-12
  G Holdings Inc. 230,903 25.01 5,774,653 2018-10-11
  G Holdings Inc. 325,072 25.15 8,174,260 2018-10-10
  G Holdings Inc. 200 25.41 5,083 2018-10-17
  G Holdings Inc. 3,357 25.44 85,415 2018-10-16
  G Holdings Inc. 28,400 25.38 720,678 2018-10-15
ARVN Arvinas Inc. Deerfield Private Design Fund Iv, L.p. 312,500 16.00 5,000,000 2018-10-01
  Kolchinsky Peter 1,000,000 16.00 16,000,000 2018-10-01
  Ratcliffe Liam (Director) 1,000,000 16.00 16,000,000 2018-10-01
  Margus Bradley Albert (Director) 40,000 16.00 640,000 2018-10-01
  Cassidy Sean A (Chief Financial Officer) 1,600 16.00 25,600 2018-10-01
  Loven Jakob (Director) 312,500 16.00 5,000,000 2018-10-01
  Shannon Timothy M (Director) 4,000 16.00 64,000 2018-10-01
  Kennedy Edward Moore Jr. (Director) 21,000 16.00 336,000 2018-10-01
  Houston John G (President and CEO) 30,000 16.00 480,000 2018-10-01
PRNB Principia Biopharma Inc. Akkaraju Srinivas (Director) 175,000 17.00 2,975,000 2018-09-18
  Glaxosmithkline Plc 270,000 17.00 4,590,000 2018-09-18
  George Simeon (Director) 270,000 17.00 4,590,000 2018-09-18
  New Leaf Bpo Management Ii, L.l.c (10% Owner) 270,000 17.00 4,590,000 2018-09-18
  Mehra Anand (10% Owner) 270,000 17.00 4,590,000 2018-09-18
  Orbimed Capital Gp Iv Llc (10% Owner) 250,000 17.00 4,250,000 2018-09-18
  Becker Daniel J. (Director) 270,000 17.00 4,590,000 2018-09-18
KOD Kodiak Sciences Inc. Profusek Robert (Director) 10,000 10.00 100,000 2018-10-09
  Baker Julian (Director) 2,500,000 10.00 25,000,000 2018-10-09
IFF International Flavors & Fragrances Inc Winder Investment Pte Ltd (10% Owner) 100,000 136.69 13,669,200 2018-10-16
  Winder Investment Pte Ltd (10% Owner) 75,201 138.34 10,403,306 2018-10-17
ACAD Acadia Pharmaceuticals Inc Baker Julian (Director) 1,210,776 18.91 22,899,406 2018-09-20
PLAN Anaplan, Inc. Beauchamp Robert E (Director) 10,000 24.21 242,130 2018-10-12
  Chung David Ying Xian (See Remarks) 3,600 17.00 61,200 2018-10-16
  Kaveripatnam Sandesh (Director) 1,104,999 17.00 18,784,983 2018-10-16
SIBN Si-bone, Inc. Bonita David P (Director) 200,000 15.00 3,000,000 2018-10-19
  Kaneko Yasunori (10% Owner) 325,000 15.00 4,875,000 2018-10-19
  Freund John Gordon (Director) 325,000 15.00 4,875,000 2018-10-19
  Orbimed Capital Gp V Llc (Director) 200,000 15.00 3,000,000 2018-10-19
  Petersen Timothy (Director) 200,000 15.00 3,000,000 2018-10-19
APPN Appian Corp Moran Colin T. (10% Owner) 53,495 28.13 1,504,814 2018-10-05
  Moran Colin T. (10% Owner) 241,446 28.37 6,849,823 2018-10-04
  Moran Colin T. (10% Owner) 80,883 28.64 2,316,489 2018-10-03
  Moran Colin T. (10% Owner) 100,000 24.84 2,484,000 2018-10-10
  Moran Colin T. (10% Owner) 66,910 26.92 1,801,217 2018-10-09
  Moran Colin T. (10% Owner) 101,300 25.37 2,569,981 2018-10-12
GTT Gtt Communications, Inc. Spruce House Investment Management Llc 282,933 44.11 12,479,891 2018-10-04
  Spruce House Investment Management Llc 105,000 44.10 4,630,290 2018-10-02
YMAB Y-mabs Therapeutics, Inc. Juan Moller San Pedro Claus (Chief Executive Officer) 31,250 16.00 500,000 2018-09-25
  Healy James 500,000 16.00 8,000,000 2018-09-21